ReShape Lifesciences Inc. (NASDAQ:RSLS) Short Interest Update

by · The Markets Daily

ReShape Lifesciences Inc. (NASDAQ:RSLS – Get Free Report) saw a large decrease in short interest during the month of October. As of October 15th, there was short interest totalling 14,700 shares, a decrease of 74.3% from the September 30th total of 57,200 shares. Currently, 3.1% of the company’s shares are sold short. Based on an average daily trading volume, of 177,700 shares, the days-to-cover ratio is presently 0.1 days.

ReShape Lifesciences Stock Down 3.4 %

Shares of NASDAQ RSLS traded down $0.19 during trading hours on Friday, hitting $5.48. The company’s stock had a trading volume of 60,444 shares, compared to its average volume of 94,874. The business has a 50-day simple moving average of $7.37 and a 200-day simple moving average of $9.91. ReShape Lifesciences has a 12 month low of $4.60 and a 12 month high of $34.22.

ReShape Lifesciences (NASDAQ:RSLS – Get Free Report) last posted its earnings results on Wednesday, August 14th. The medical device company reported ($3.48) earnings per share (EPS) for the quarter. ReShape Lifesciences had a negative net margin of 112.11% and a negative return on equity of 208.37%. The business had revenue of $1.97 million for the quarter.

Analysts Set New Price Targets

Separately, Maxim Group reissued a “hold” rating on shares of ReShape Lifesciences in a report on Wednesday, July 17th.

Read Our Latest Analysis on RSLS

ReShape Lifesciences Company Profile

(Get Free Report)

ReShape Lifesciences Inc provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band in order to optimize an individual's comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus.

Further Reading